Protagenic Therapeutics, Inc.\new Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Protagenic Therapeutics, Inc.\new quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q4 2024.
  • Protagenic Therapeutics, Inc.\new Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 4.9M shares, a 12.8% increase year-over-year.
  • Protagenic Therapeutics, Inc.\new annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 4.9M shares, a 12.8% increase from 2023.
  • Protagenic Therapeutics, Inc.\new annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 4.34M shares, a 0.62% increase from 2022.
  • Protagenic Therapeutics, Inc.\new annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 4.32M shares, a 17.2% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 4.9M +555K +12.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 4.53M +198K +4.58% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 4.44M +112K +2.59% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 4.44M +117K +2.72% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 4.34M +26.7K +0.62% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 4.33M +9.64K +0.22% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 4.33M +10.8K +0.25% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 4.32M +9.46K +0.22% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 4.32M +633K +17.2% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
Q3 2022 4.32M -12.2M -73.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 4.32M -10.2M -70.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 4.31M -6.21M -59% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 3.69M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 16.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 14.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 10.5M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2015 400M 0 0% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-11
Q4 2014 400M 0 0% Oct 1, 2014 Dec 31, 2014 10-Q 2015-02-06
Q3 2014 400M 0 0% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-13
Q2 2014 400M Apr 1, 2014 Jun 30, 2014 10-K 2014-10-14
Q1 2014 400M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 400M Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-06
Q3 2013 400M Jul 12, 2013 Sep 30, 2013 10-Q 2014-11-13
Q3 2011 6.3M +1.08M +20.8% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-14
Q2 2011 6.32M +1.1M +21.1% Apr 1, 2011 Jun 30, 2011 10-Q/A 2011-09-07
Q3 2010 5.22M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 5.22M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.